PANACEA BIOTEC
|
The Current P/E Ratio of PANACEA BIOTEC is -69.57.
Share Price | ₹138.4 | Apr 23,2024 |
Market Cap | ₹848.1 Cr | |
Earnings-TTM | ₹-12.2 Cr | TTM-Consolidated Results |
Price/Earnings | -69.57x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PANACEA BIOTEC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹848.1 Cr] as on Apr 23,2024
(/) Earnings [ ₹-12.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -69.57x ]
Thus, for PANACEA BIOTEC , the investors are currently willing to pay -69.57 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PANACEA BIOTEC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PANACEA BIOTEC over the last five years.
Historical PE (Price/Earnings) ratio chart of PANACEA BIOTEC
PE Ratio Performance Analysis for PANACEA BIOTEC
- PANACEA BIOTEC 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 6.60x.
- PANACEA BIOTEC 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PANACEA BIOTEC 's p/e ratio peaked in Mar2019 at 32.18x.
- PANACEA BIOTEC 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does PANACEA BIOTEC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PANACEA BIOTEC | -12.19 | -69.57 | 848.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 39.56 | 356,001.0 |
CIPLA LTD | 3,744.03 | 29.06 | 108,813.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.07 | 99,325.3 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 32.68 | 96,553.2 |
DIVIS LABORATORIES LTD | 1,382.97 | 72.36 | 100,075.0 |
MANKIND PHARMA LTD | 1,743.30 | 55.01 | 95,896.9 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 59.72 | 89,224.4 |
LUPIN LTD | 1,809.74 | 39.80 | 72,033.6 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.05 | 64,043.1 |
ABBOTT INDIA LTD | 1,145.58 | 47.75 | 54,704.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PANACEA BIOTEC 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -69.57x |
Max industry PE | 72.36x |
Median industry PE | 39.56x |
Average industry PE | 31.68x |
You may also like the below Video Courses